Literature DB >> 315416

T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells.

R N Pahwa, S G Pahwa, R A Good.   

Abstract

A study of T-lymphocyte differentiation was made on fractionated bone marrow cells from normal volunteers and from 11 patients with severe combined immunodeficiency (SCID) using normal thymic epithelial monolayers and their culture supernates as inducing agents. Normal marrow cells could regularly be induced to bear the human T-lymphocyte antigen (HTLA), to form rosettes with sheep erythrocytes (E rosettes), and to respond to the mitogen concanavalin A (Con A) after coculture with the thymic epithelial monolayers or their culture supernates. In contrast, studies of T-cell differentiation on the marrow cells of patients with SCID revealed varying defects, ranging from a complete "absence" of definable T-cell precursors to partial differentiation resulting in acquisition of one (HTLA) or two (HTLA and E rosettes) markers for T lymphocytes. Only in one patient was there induction of all three T-cell markers, namely, HTLA, E rosettes, and responsiveness to Con A. These observations indicate that SCID is a heterogeneous disorder in which defects of differentiation can occur at one or more multiple sites of differentiation leading the the clinical expression of T- and B-cell dysfunction. Further, our studies indicate that in T-cell differentiation, HTLA probably appears before the capacity to form E-rosettes, and development of the latter capacity is followed by a state of responsiveness to mitogens. A scheme of normal differentiation along with the defects of precursor T cells seen in SCID is presented.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315416      PMCID: PMC371317          DOI: 10.1172/JCI109625

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Induction of T-lymphocyte differentiation by thymic epithelial cell monolayers.

Authors:  J I Willis-Carr; H D Ochs; R J Wedgwood
Journal:  Clin Immunol Immunopathol       Date:  1978-07

2.  T-lymphocyte differentiation in severe combined immunodeficiency: defects of the thymus.

Authors:  R N Pahwa; S G Pahwa; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1978-12

3.  Morphological and functional maturation of human thymic epithelium in culture.

Authors:  K W Pyke; E W Gelfand
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

4.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Sequential stages of human T lymphocyte differentiation.

Authors:  J L Touraine; J W Hadden; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

6.  Cultured thymic epithelium (CTE) in severe combined immunodeficiency.

Authors:  R Hong; H Schulte-Wissermann; S Horowitz; M Borzy; J Finlay
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

7.  T-lymphocyte differentiation in vitro in primary immunodeficiency diseases.

Authors:  J L Touraine; G S Incefy; F Touraine; P L'Esperance; F P Siegal; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1974-11

8.  Early stages of human marrow lymphocyte differentiation: induction in vitro by thymopoietin and ubiquitin.

Authors:  W A Kagan; F P Siegal; S Gupta; G Goldstein; R A Good
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

9.  Heterogeneity of stem cells in severe combined immunodeficiency.

Authors:  G S Incefy; E Grimes; W A Kagan; G Goldstein; E Smithwick; R O'Reilly; R A Good
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

10.  Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency.

Authors:  R Pahwa; S Pahwa; R A Good; G S Incefy; R J O'Reilly
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  4 in total

1.  Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Authors:  R Pahwa; T Chatila; S Pahwa; C Paradise; N K Day; R Geha; S A Schwartz; H Slade; N Oyaizu; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders.

Authors:  E L Reinherz; M D Cooper; S F Schlossman; F S Rosen
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

3.  Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

Authors:  E L Reinherz; R Geha; J M Rappeport; M Wilson; A C Penta; R E Hussey; K A Fitzgerald; J F Daley; H Levine; F S Rosen; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

4.  Heterogeneity of b lymphocyte differentiation in severe combined immunodeficiency disease.

Authors:  S G Pahwa; R N Pahwa; R A Good
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.